Open-label study on treatment with 20 % subcutaneous IgG administration in polymyositis and dermatomyositis

The objective of this study is to describe the benefit of 20 % subcutaneous infusions of immunoglobulin (SCIg) in patients with dermatomyositis (DM) or polymyositis (PM) after a switch from previous 16 % SCIg treatment. Eight patients with DM or PM, who met the Bohan and Peter’s criteria, previously...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical rheumatology 2014-04, Vol.33 (4), p.531-536
Hauptverfasser:	Danieli, Maria Giovanna, Moretti, Romina, Gambini, Simona, Paolini, Luca, Gabrielli, Armando
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Child Cohort Studies Dermatomyositis - drug therapy Female Humans Immunoglobulin G - administration & dosage Immunologic Factors - administration & dosage Infusions, Subcutaneous Medicine Medicine & Public Health Middle Aged Original Article Patient Satisfaction Polymyositis - drug therapy Prospective Studies Rheumatology Treatment Outcome Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!